Please login to the form below

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years. Whenever global health crises such as these emerge, the pharmaceutical industry comes under intense scrutiny for not having an immediate solution available. Part of the problem is that prevention is not always financially viable; the substantial R&D costs of developing vaccines or treatments for all known and potential threats that may or may not one day develop into global pandemics is not a feasible burden for the industry to carry alone...

http://www.researchpartnership.com/news/2017/01/cool-heads-in-a-crisis/

25th January 2017

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Video
Virtual Conference Live
Research Partnership
Report
Digital Health Tools - Physician Trends
Research Partnership
Live webinar:
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
Research Partnership’s MedTech Division appoints two Directors
Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
Putting behavioural science at the forefront of market research
Research Partnership